Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions

Author:                                  

Publisher: Spandidos Publications

E-ISSN: 1791-3004|12|5|6849-6854

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.12, Iss.5, 2015-01, pp. : 6849-6854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content